We establish that CD4+ T cells are the primary cells driving meta-inflammation via TNF-α in T2DM patients through STAT3 and provide an inclusive characterization of chronic low-grade inflammation in T2DM patients. The gene discussed is CD4; the disease is type 2 diabetes mellitus.